Selenium metabolism;Métabolisme du sélénium

EMC - Endocrinologie

Volumn 1, Issue 1, 2004, Pages 19-28

  Ducros, V ^a   Favier, A ^a  

^a HÔPITAL MICHALLON   (France)

Author keywords

Deficiency; Dietary intake; Disease prevention; Metabolism; Selenium; Selenoproteins

Indexed keywords

EID: 33645727479     PISSN: 17425653     EISSN: 17425653     Source Type: Journal    
DOI: 10.1016/j.emcend.2003.10.001     Document Type: Short Survey

References (56)

1. Schwarz K, Foltz CM. Selenium as an integral part of factor 3 against necrotic dietary liver degeneration. J Am Chem Soc 1957;79:3292-3293.
2. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973;179: 588-590.
3. Robinson MF, Campbell DR, Stewart RD, Rea HM, Thomson CD, Snow PG, et al. Effect of daily supplements of selenium on patients with muscular complaints in Otago and Canterbury. New Zealand Med J 1981;93:289-291.
4. Van Rij AM, Thomson CD, McKenzie JM, Robinson MF. Selenium deficiency in total parenteral nutrition. Am J Clin Nutr 1979;32:2076-2085.
5. Keshan Disease Research Group. Observations on effects of sodium selenite in prevention of Keshan Disease. Chinese Med J 1979;92:471-476.
6. Hatfield DL, Gladyshev VN. How selenium has altered our understanding of the genetic code. Mol Cell Biol 2002;22: 3565-3576.
7. Avissar N, Whitin JC, Allen PZ, Wagner DD, Liegey P, Cohen HJ. Plasma selenium-dependent glutathione peroxidase. Cell origin and secretion. J Biol Chem 1989;264: 15850-15855.
8. Whitin JC, Bhamre S, Tham DM, Cohen HJ. Extracellular glutathione peroxidase is secreted basolaterally by human renal proximal tubule cells. Am J Physiol Renal Physiol 2002;281:F20-F28.
9. Food and Nutrition Board, Institute of Medicine. Selenium. Dietary reference intake for vitamin C, vitamin E, selenium, and carotenoids. Washington: National Academy Press; 2000. p. 284-324.
10. Duffield A, Thomson C, Hill K, Williams S. An estimation of selenium requirements for new Zealanders. Am J Clin Nutr 1999;70:896-903.
11. Ducros V. Selenium. In: Martin A, editor. Apports nutritionnels conseillés pour la population française. Paris: Tec et Doc; 2000. p. 165-168.
12. Ducros V, Faure P, Ferry M, Couzy F, Biajoux I, Favier A. The sizes of the exchangeable pools of selenium in elderly women and their relation to institutionalization. Br J Nutr 1997;78:379-396.
13. Lescure A, Fagegaltier D, Carbon P, Krol A. Protein factors mediating selenoprotein synthesis. Curr Protein Pept Sci 2002;3:143-151.
14. Saito Y, Hayashi T, Tanaka A, Watanabe Y, Suzuki M, Saito E, et al. Selenoprotein P in human plasma as an extracellular phospholipid hydroperoxide glutathione peroxydase. Isolation and enzymatic characterization of human. J Biol Chem 1999;274:2866-2871.
15. Behne D, Kyriakopoulos A. Mammalian selenium-containing proteins. Annu Rev Nutr 2001;21:453-473.
16. Richard MJ, Belleville F, Chalas J, Ceballos-Picot I, Vitoux D, Boyer MJ, et al. Les glutathion peroxydases: intérêt de leur dosage en biologie clinique. Ann Biol Clin 1997;55:195-207.
17. Behne D, Kyriakopoulos A, Meinhold H, Köhrle J. Identification of type I iodothyronine 5′-deiodinase as a selenoenzyme. Biochem Biophys Res Commun 1990;173:1143-1149.
18. Berry MJ, Banu L, Larsen PR. Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 1991; 349:438-440.
19. Arthur J, Nicol F, Hutchinson A, Beckett G. The effects of selenium depletion and repletion on the metabolism of thyroid hormones in the rat. J Inorg Chem 1990;39: 101-108.
20. Vanderpas JB, Contempré B, Duale NL, Goosens W, Bebe N, Thorpe R, et al. Iodine and selenium deficiency associated with cretinism in northern Zaire. Am J Clin Nutr 1990;52: 1087-1093.
21. Vanderpas JB, Contempré B, Duale NL, Deckx H, Bebe N, Longombé AO, et al. Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects. Am J Clin Nutr 1993;57:271S-275S.
22. Hill KE, Xia Y, Akesson B, Boeglin ME, Burk RF. Selenoprotein P concentration in plasma as an index of selenium-supplemented Chinese subjects. J Nutr 1996;126:138-145.
23. Burk RF, Hill KE, Boeglin ME, Ebner FF, Chittum HS. Selenoprotein P associates with endothelial cells in rat tissues. Histochem Cell Biol 1997;108:11-15.
24. Saito Y, Takahashi K. Characterization of selenoprotein P as a selenium supply protein. Eur J Biochem 2002;269: 5746-5751.
25. Mostert V. Selenoprotein P: properties, functions and regulation. Arch Biochem Biophys 2000;376:433-438.
26. Tujebajeva RM, Harney JW, Berry MJ. Selenoprotein P expression, purification, and immunochemical characterization. J Biol Chem 2000;275:6288-6294.
27. Arteel GE, Mostert V, Oubrahim H, Briviba K, Abel J, Sies H. Protection by selenoprotein P in human plasma against peroxynitrite-mediated oxidation and nitration. Biol Chem 1998;379:1201-1205.
28. Saito Y, Takahashi K. Selenoprotein P: its structure and functions. J Health Sci 2000;46:409-413.
29. Yang X, Hill KE, Maguire MJ, Burk RF. Synthesis and secretion of selenoprotein P by rat astrocytes. Biochem Biophys Acta 2000;1474:390-396.
30. Yan J, Barrett JN. Purification from bovine serum of a survival-promoting factor for cultured central neurons and its identification as selenoprotein P. J Neurosci 1998; 18: 8682-8691.
31. Dreher I, Jakobs TC, Kohrle J. Cloning and characterization of the human selenoprotein P promoter. J Biol Chem 1997;272:29364-29371.
32. Mostert V, Dreher I, Kohrle Abel J. Transforming growth factor-beta 1 inhibits expression of selenoprotein P in humain liver cells. FEBS Lett 1999;460:23-26.
33. Tamura T, Stadtman TC. A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity. Proc Natl Acad Sci USA 1996;93:1006-1011.
34. Berggren M, Gallegos A, Gadaska JR, Gadaska PY, Warneke J, Powis G. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res 1996;16:3459-3466.
35. Didier C, Kerblat I, Drouet C, Favier A, Beani JC, Richard MJ. Induction of thioredoxin by ultraviolet-A radiation prevents oxidative-mediated cell death in human skin fibroblasts. Free Radic Biol Med 2001;31:585-598.
36. Sun QA, Kinarsky L, Sherman S, Gladyshev V. Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems. Proc Natl Acad Sci USA 2001;98: 3673-3678.
37. Kryukov GV, Kumar RA, Koc A, Sun I, Gladyshev VN. Selenoprotein R is a zinc-containing stereo-specific methionine sulfoxide reductase. Proc Natl Acad Sci USA 2002;99:4245-4250.
38. Ursini F, Heim S, Kiess M, Maiorino M, Roveri A, Wissing J, et al. Dual function of the selenoprotein PHGPx during sperm maturation. Science 1999;285:1393-1396.
39. Jeong D, Kim TS, Chung YW, Lee BJ, Kim I. Selenoprotein W is a glutathione-dependent antioxidant in vivo. FEBS letters 2002;517:225-228.
40. Behne D, Pfeifer H, Röthlein D, Kyriakopoulos. Cellular and subcellular distribution of selenium and selenium-containing proteins in the rat. In: Roussel AM, Anderson RA, Favier AE, editors. Trace elements in Man and Animals. Proceedings of the tenth international symposium on trace elements in man and animals. New York: Plenum Press; 2000. p. 29-33.
41. Behne D, Hilmert H, Scheid S, Gessner H, Elger W. Evidence for specific selenium target tissues and new biologically important selenoproteins. Biochim Biophys Acta 1988;966: 12-21.
42. Behne D, Weiss-Nowak C, Kalcklösch M, Westphal C, Gessner H, Kyriakopoulos A. Studies on the distribution and characteristics of new mammalian selenium-containing proteins. Analyst 1994;120:823-825.
43. Rayman MP, Clark LC. Selenium in cancer prevention. In: Roussel AM, Anderson RA, Favier AE, editors. Trace Elements in Man and Animals. New York: Plenum Press; 2000. p. 575-580 Proceedings of the tenth international symposium on trace elements in man and animals.
44. Kiremidjian-Schumacher L, Roy M, Wishe HI, Cohen MW, Stotzky G. Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells. Biol Trace Elem Res 1994;41: 115-127.
45. Roy M, Kiremidjian-Schumacher L, Wishe HI, Cohen MW, Stotzky G. Supplementation with selenium and human immune cell functions. I. Effect on lymphocyte proliferation and interleukin 2 receptor expression. Biol Trace Elem Res 1994;41:103-114.
46. Rayman MP. The importance of selenium to human health. Review. Lancet 2000;356:233-241.
47. Beck MA, Shi Q, Morris VC, Levander OA. Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat Med 1995;1:433-436.
48. Sappey C, Legrand-Poels S, Best-Belpomme M, Favier A, Rentier B, Piette J. Stimulation of glutathione peroxidase activity decreases HIV type 1 activation after oxidative stress. AIDS Res Hum Retrovir 1994;10:1451-1461.
49. Berr C, Balansard B, Arnaud J, Roussel AM, Alperovitch A. Cognitive decline is associated with systemic oxidative stress: the EVA study. J Am Geriatr Soc 2000;48: 1285-1291.
50. Hawkes WC, Hornbostel L. Effects of dietary selenium on mood in healthy men living in a metabolic research unit. Biol Psychiatry 1996;39:121-128.
51. Ip C, Thompson HJ, Zhu Z, Ganther HE. In vitro and in vivo studies of methylselenic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemopreventive. Cancer Res 2000;60:2882-2886.
52. Neve J. Rôle essentiel et indications cliniques du sélénium. Méd Hyg 1993;51:741-746.
53. Thérond P, Malvy D, Favier A. Toxicité du sélénium à doses pharmacologiques par voie orale. Nutr Clin Metabol 1997; 11:91-101.
54. Neve J. Le sélénium. Dossier scientifique de l'Institut Français pour la Nutrition 1995;7:71-76.
55. Levander OA, Whanger PD. Deliberations and evaluations of the approaches, endpoints and paradigms for selenium and iodine dietary recommendations. J Nutr 1996;126: 2427S-2434S.
56. Martin A. Sélénium. Conseil Supérieur d'Hygiène Publique de France, Les limites de sécurité dans les consommations alimentaires des vitamines et des minéraux. Paris: Technique et Documentation, Lavoisier; 1996. p. 35-56.